SHAREHOLDER ALERT: Weiss Law Investigates TherapeuticsMD, Inc.
prnewswire.com
news
2022-05-31 22:10:00

NEW YORK, May 31, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), in connection with the proposed acquisition of the Company via a tender offer by funds managed by an affiliate of EW Healthcare Partners.  Under the terms of the merger agreement, the Company's shareholders will receive $10.00 in cash for each share of TherapeuticsMD common stock owned.
